![Manuel Lopez-Figueroa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Manuel Lopez-Figueroa
Directeur/Membre du Conseil chez
ORYZON GENOMICS S.A.
Profil
Manuel Lopez-Figueroa is the founder of Cantero Therapeutics, Inc., founded in 2018, where the title held is Director.
Current jobs include Director at Zulia Biotech, Inc.; Lead Independent Director at Oryzon Genomics SA since 2020; Investment Advisor at Nina Capital SGEIC SA since 2019; Advisor at Bay City Capital LLC since 2021; Operating Partner at Civilization Ventures LLC starting in 2026; and Chief Operating Officer at IMIDomics, Inc. since 2015.
Education history includes a graduate degree from La Laguna University Of in 1991 and a doctorate from the University of Copenhagen in 1996.
Postes actifs de Manuel Lopez-Figueroa
| Sociétés | Poste | Début |
|---|---|---|
| ORYZON GENOMICS S.A. | Directeur/Membre du Conseil | 11/05/2020 |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Consultant / Advisor | 07/07/2021 |
Imidomics, Inc.
 Imidomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of medicines for immune-mediated inflammatory diseases | Directeur des opérations | 01/06/2015 |
Cantero Therapeutics, Inc. | Fondateur | 01/01/2018 |
Zulia Biotech, Inc. | Directeur/Membre du Conseil | - |
Nina Capital SGEIC SA
 Nina Capital SGEIC SA Investment ManagersFinance Nina Capital invests in companies located in Pan European, United Kingdom, United States, Canada, Israel and Australia. The firm focuses on health and technology. It participates in pre-seed, seed, and early stage transactions with investment size ranging between EUR 0.2 million and EUR 1.5 million. The firm makes co-investments. It also acts as lead investor and makes follow-on investments. | Consultant / Advisor | 01/01/2019 |
Civilization Ventures LLC
 Civilization Ventures LLC Investment ManagersFinance Civilization Ventures invests in companies located in the United States. The firm focuses on health tech and biology-driven innovation sectors. It participates in seed, early and later stage capital requirements. | Private Equity Investor | 01/06/2026 |
Formation de Manuel Lopez-Figueroa
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Oryzon Genomics SA
 Oryzon Genomics SA BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops epigenetics-based therapeutics | Health Technology |
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Finance |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
La Laguna University Of
 La Laguna University Of Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Civilization Ventures LLC
Civilization Ventures LLC Investment ManagersFinance Civilization Ventures invests in companies located in the United States. The firm focuses on health tech and biology-driven innovation sectors. It participates in seed, early and later stage capital requirements. | Finance |
Imidomics, Inc.
Imidomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of medicines for immune-mediated inflammatory diseases | Commercial Services |
Nina Capital SGEIC SA
Nina Capital SGEIC SA Investment ManagersFinance Nina Capital invests in companies located in Pan European, United Kingdom, United States, Canada, Israel and Australia. The firm focuses on health and technology. It participates in pre-seed, seed, and early stage transactions with investment size ranging between EUR 0.2 million and EUR 1.5 million. The firm makes co-investments. It also acts as lead investor and makes follow-on investments. | Finance |
Cantero Therapeutics, Inc. | |
Zulia Biotech, Inc. |
